StockGlow
StandoutsLearnAbout

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc.

$426.70-0.00%Healthcare
Compare ISRG with
StockGlow Score
54
Neutral
BearishBullish

Scored against other Healthcare stocks, not a fixed scale.

The quick read

Intuitive Surgical reads as neutral right now, with no clear lean either way.

What's working
Its finances look solid, with manageable debt and a healthy cash cushion.
Worth watching
You're paying more for it than for most other healthcare companies, relative to what it earns.
1 year ago-21.9%

Analyst price target

~12-month · 30 analysts
$478.53average target+12.1% vs now
Now $426.70
Low $324.00High $685.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$150.74B
52-wk high
$603.88
52-wk low
$328.57
50-day avg
$391.67
200-day avg
$439.63
Trailing P/E
48.9

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally…

Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
17,021
Headquarters
Sunnyvale, CA
intuitive.com

Similar stocks

VRTXVertex Pharmaceuticals Incorporated$499.74-1.77%NOWServiceNow, Inc.$141.97-4.44%CRMSalesforce, Inc.$240.70-2.45%LRCXLam Research Corporation$263.94-4.87%

What’s behind the score

Valuation

P/E ratio11

P/E 48.9 — lower than 11% of Healthcare peers

Price / book25

P/B 8.3 — lower than 25% of Healthcare peers

Price / sales7

P/S 13.7 — lower than 7% of Healthcare peers

EV / EBITDA0

EV/EBITDA 34.8 — lower than 0% of Healthcare peers

EV / revenue7

EV/Revenue 13.2 — lower than 7% of Healthcare peers

PEG ratio30

PEG 2.0 — lower than 30% of Healthcare peers

Free cash flow yield10

FCF yield 1.7% — higher than 10% of Healthcare peers

Profitability & quality

Gross margin60

Gross margin 66.7% — higher than 60% of Healthcare peers

Operating margin77

Operating margin 33.6% — higher than 77% of Healthcare peers

Net margin93

Net margin 28.4% — higher than 93% of Healthcare peers

Return on equity78

ROE 17.4% — higher than 78% of Healthcare peers

Return on assets76

ROA 10.5% — higher than 76% of Healthcare peers

Cash-backed earnings42

Free cash flow is 83% of reported net income

Financial health

Current ratio100

Current ratio 4.96 — higher than 100% of Healthcare peers

Quick ratio100

Quick ratio 3.64 — higher than 100% of Healthcare peers

Debt / EBITDA97

Debt/EBITDA 0.00 — lower than 97% of Healthcare peers

Growth

Revenue growth93

Revenue growth 18.5% YoY — higher than 93% of Healthcare peers

Earnings growth58

Earnings growth 26.5% YoY — higher than 58% of Healthcare peers

Ownership & investor activity

Dividend payout ratio53

Payout ratio 0.0% — somewhat unusual vs Healthcare peers

Insider buying / selling50

Net insider buying, +0.0% of insider shares

Institutional buying / selling49

Institutions net sold, -11.2% of shares held

Insider ownership3

Insiders hold 0.5% of shares outstanding

Short interest86

2.1% of float sold short

Momentum

Price trend47

Mixed vs its moving averages

52-week range36

36% of the way from its 52-week low to high

The StockGlow Score is a snapshot of current, reported fundamentals scored against sector peers, plus price trend — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Stock basics·Privacy